Skip to main content

Table 2 Node vulnerabilities

From: Towards targeted combinatorial therapy design for the treatment of castration-resistant prostate cancer

Node

Vulnerability (%)

1

6.25

2

6.25

3

6.25

4

6.25

5

6.25

6

6.25

7

24.98

8

6.25

9

6.25

10

24.98

11

24.98

12

24.98

13

24.98

14

12.47

15

12.47

16

6.25

17

6.25

18

6.25

19

1.57

20

1.57

21

1.57

22

1.57

23

1.57

24

24.98